R&D TAX RELIEF AND CLINICAL TRIALS: WHAT THERAPEUTIC COMPANIES CAN (AND CAN’T) CLAIM IN THE UK
For therapeutic companies, clinical trials are often the largest and most complex component of R&D expenditure. Yet they are also one [...]
For therapeutic companies, clinical trials are often the largest and most complex component of R&D expenditure. Yet they are also one [...]
For businesses claiming R&D tax relief in the UK, one of the key considerations is whether the claim should be prepared [...]
It’s a common assumption that if something feels new, innovative, or technically complex, it must qualify as R&D for UK tax [...]
New Merged R&D Tax Expenditure Credit Scheme - FAQs What is the new Merged R&D Expenditure Credit Scheme? The Merged [...]
SUMMARY Overall, the government is looking to encourage investment into R&D. The introduction of a single scheme is aimed at [...]
Key points in HMRC’s guidance On 31 October 2023, HMRC released detailed guidance on how companies can check whether their [...]
A claim for R&D Tax Relief is made in the company's corporation tax return for the period to which the [...]
Following concerns that the SME R&D Tax relief scheme is not delivering the anticipated benefits, the chancellor today announced an over [...]
Having been involved in numerous R&D claims, I'd like to share some basic tips/points for consideration when preparing a company's R&D claims: (i) [...]
Background At the Spring Budget 2021, the government launched a review of the two R&D Tax relief schemes. The government’s objectives for review were primarily [...]
“MYTHS ARE FUN, AS LONG AS YOU DON’T CONFUSE THEM WITH THE TRUTH.” Richard Dawkins, Biologist R&D Tax reliefs are [...]
Today’s budget has reinforced UK’s ambitions to become the new scientific Superpower, prioritising growth and high-tech investment. As [...]
BACKGROUND The R&D Tax incentives scheme was introduced in the year 2000 for Small and Medium-sized entities (SMEs). The scheme [...]
In these uncertain times as businesses start implementing continuity plans, cash flow planning becomes even more important. Whilst the government [...]
Having visited numerous companies over the recent months to discuss their R&D claims (or the potential to make one), [...]